It's a very welcome move: Kiran Mazumdar-Shaw on WHO's nod for Covaxin

Watch: Kiran Mazumdar-Shaw on Covaxin getting approval for emergency use for children aged 12

Lockdown 4.0: Is leeway to states right move? Kiran Mazumdar-Shaw shares her perspective

Don't think the budget has moved the needle in improving consumption, says Kiran Mazumdar Shaw of Biocon

स्वदेशी वैक्सीन Covaxin पर बड़ी खबर | Bharat Biotech gets nod to move to phase 2 trials of Covaxin

kiran-mazumdar-shaw-at-global-technology-summit

Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections

Kiran Mazumdar Shaw On Fighting and Recovering From COVID-19: ‘Dont Panic, Be Positive

Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw

Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook

Safe place to be in if coronavirus mortality rate brought down: Kiran Mazumdar Shaw

Kiran Mazumdar-Shaw on why India needs to open up after May 3rd 

Kiran Mazumdar-Shaw | Compassionate capitalism

Kiran Mazumdar-Shaw | Entrepreneurship made me aware of social needs

Kiran Mazumdar-Shaw | Certain investments should be considered philanthropic

Look forward to an IPO in next 18-24 months, says Biocon’s Kiran Mazumdar Shaw

Kiran Mazumdar Shaw Backs Sikka & Team

Kiran Mazumdar Shaw: The entrepreneur ahead of her time

Shah Rukh Khan calls Kiran Mazumdar Shaw a role model (GOSSIP)

Kiran Mazumdar-Shaw | Advice to new philanthropists: where can you make a difference?

Kiran Mazumdar-Shaw | Philanthropic focus on research

Kiran Mazumdar Shaw of Biocon on business outlook

Interview: Biocon MD, Kiran Mazumdar Shaw

Q2WithBQ With Biocon's Kiran Mazumdar Shaw

Profit Insights | Biocon's Kiran Mazumdar Shaw Exclusive | NDTV Profit

Corporate tax cut is a much needed reform, says Biocon's Kiran Mazumdar Shaw

Digvijaya Singh in race for Congress president post

Priyank Sharma, Dhanashree Verma share memories of Maine Payal Hai Chhankai, working with Neha Kakkar | Exclusive

Ashok Gehlot reaches Delhi to meet Congress leader Sonia Gandhi

After sweeping pan-India raids, Centre bans radical outfit PFI over alleged terror funding; more

Assam CM welcomes ban on PFI, says radicals will be dealt with iron fist; more

PFI, 8 associated fronts now declared 'unlawful organisations'; Congress demands RSS ban; more

Biocon and HealthCare Global In Focus | Earnings Edge | NDTV Profit

Q1 Review: Biocon's Profit, Margins Fall; Misses Estimates

Q4 Review | Biocon March Quarter Net Profit Soars

Stocks In Focus: Biocon, CG Power and Industrials, LIC & More

Q2 Review: After Weak Q2, Can Biocon Bounce Back In Q3? | BQPrime

Biocon Withdraws Drug Application With EMA